What is Vor Biopharma's PP&E (net)?

Vor Biopharma (VOR) reported PP&E (net) of $565K in Q1 2026.

How has Vor Biopharma's PP&E (net) changed year-over-year?

Vor Biopharma's PP&E (net) decreased by 90.6% year-over-year, from $5.99M to $565K.

What is the long-term trend for Vor Biopharma's PP&E (net)?

Over 5 years (2020 to 2025), Vor Biopharma's PP&E (net) has grown at a -35.4% compound annual growth rate (CAGR), from $4.73M to $533K.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Vor Biopharma VOR PP&E (Net)

PP&E (Net) at other companies

Johnson & JohnsonJNJ

$23.27B+11.5%

AmgenAMGN

$8.22B+23.0%

Dianthus TherapeuticsDNTH

$274K+43.5%

Cullinan Therapeutics, Inc.CGEM

$342K-43.7%

Design Therapeutics, Inc.DSGN

$824K-40.2%

Janux TherapeuticsJANX

$3.55M-28.3%

Other financials

Income statement

See full

Operating income-$35.2M-5.6%

Net income-$219.6M-576%

EPS (diluted)-$5.11+1.9%

Balance sheet

See full

Cash & equivalents$169.9M+239%

Total debt$2.9M-90.5%

Total equity-$150.4M-328%

Total assets$506.7M+364%

Cash flow

See full

Operating cash flow-$38.2M-23.1%

CapEx$48.0K-79.2%

Free cash flow-$38.3M-22.4%

Valuation

See full

Market cap$784.61M+2,513%

Enterprise value$617.68M+5,639%

Returns & leverage

See full

Return on equity-125.4%+671pp

Debt / equity0.5×+0.2×

Current ratio31.1×+27.3×

Where this comes from

Reported directly by Vor Biopharma in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Vor Biopharma’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vor Biopharma's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vor Biopharma's PP&E (net)?: Vor Biopharma (VOR) reported PP&E (net) of $565K in Q1 2026.
How has Vor Biopharma's PP&E (net) changed year-over-year?: Vor Biopharma's PP&E (net) decreased by 90.6% year-over-year, from $5.99M to $565K.
What is the long-term trend for Vor Biopharma's PP&E (net)?: Over 5 years (2020 to 2025), Vor Biopharma's PP&E (net) has grown at a -35.4% compound annual growth rate (CAGR), from $4.73M to $533K.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.